Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Myelodysplastic Syndromes 14Myeloproliferative Disorders 9Hodgkin Disease 8Multiple Myeloma 7Lymphoma, Non-Hodgkin 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Hematologic Neoplasms 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia 6Anemia, Refractory, with Excess of Blasts 6Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Prolymphocytic 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphoid 3Graft vs Host Disease 3Congenital Abnormalities 3Blast Crisis 3Anemia, Aplastic 3

Interventions

ibrutinib 2fludarabine 2asciminib 2Sirolimus 2Mycophenolic Acid 2Cyclophosphamide 2ruxolitinib 1axatilimab 1Whole-Body Irradiation 1Specimen Handling 1Panobinostat 1Mesna 1Filgrastim 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchiolitis Obliterans Syndrome × Whole-Body Irradiation × 90 days × Clear all
NCT04959175 2026-04-28

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
320 enrolled
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡